MUSCLE-INVASIVE BLADDER CANCER
Clinical trials for MUSCLE-INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new MUSCLE-INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for MUSCLE-INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink bladder tumors before surgery
Disease control Recruiting nowThis study tests a drug called erdafitinib, alone or with another drug (cetrelimab), given before surgery to people with muscle-invasive bladder cancer whose tumors have certain gene changes (FGFR). The goal is to see if these drugs can shrink or eliminate the cancer before the b…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated May 16, 2026 22:33 UTC
-
New drug combo may let bladder cancer patients keep their bladder
Disease control Recruiting nowThis study tests a combination of two drugs, enfortumab vedotin and pembrolizumab, in people with muscle-invasive bladder cancer. The goal is to see if this treatment can eliminate the cancer and allow patients to keep their bladder instead of having it surgically removed. The st…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 16, 2026 22:29 UTC
-
New drug duo aims to stop bladder cancer from coming back
Disease control Recruiting nowThis study tests whether a combination of two drugs (sacituzumab govitecan and nivolumab) given after surgery can keep bladder cancer from returning in patients at high risk. About 23 adults who have had their bladder or part of their urinary tract removed will receive the treatm…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New study tests if MRI can spare bladder cancer patients from invasive biopsy
Diagnosis Recruiting nowThis pilot study is testing whether a special MRI scan (mpMRI) can accurately detect muscle-invasive bladder cancer without needing a surgical biopsy (TURBT). About 30 adults with suspected muscle-invasive bladder cancer will get both tests, and researchers will compare the resul…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: NA • Sponsor: University of California, Irvine • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC
-
New MRI method could speed up bladder cancer diagnosis and treatment
Diagnosis Recruiting nowThis study compares two ways to diagnose muscle-invasive bladder cancer: the standard procedure (TURBT) versus an MRI followed by a same-day biopsy. About 360 adults with suspected muscle-invasive bladder cancer will take part. The goal is to see if the MRI approach leads to fast…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated May 04, 2026 16:19 UTC
-
Bladder cancer study: does chemo fool the MRI?
Knowledge-focused Recruiting nowThis study looks at whether chemotherapy given before bladder cancer surgery changes how well an MRI can see the tumor. Researchers will compare MRI results from patients who had chemo first to those who went straight to surgery. The goal is to see if chemo-related tissue changes…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: NA • Sponsor: Assiut University • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Thousands of cancer patients help build better detection tests
Knowledge-focused Recruiting nowThis study collects blood and leftover tissue samples from 9,600 adults with different types of cancer, such as breast, lung, and pancreatic cancer. Researchers will use these samples to improve tests that look for tiny bits of cancer DNA in the blood, which may help detect if ca…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC